Valuation: Neuland Laboratories Limited

Market Cap 295B 3.09B 2.64B 2.47B 2.26B 4.27B 4.31B 29.17B 11.37B 148B 11.59B 11.34B 492B P/E 2027 *
61.6x
P/E 2028 * 47.2x
Enterprise Value 297B 3.11B 2.67B 2.5B 2.28B 4.31B 4.35B 29.42B 11.47B 150B 11.69B 11.44B 496B EV / Sales 2027 *
12.2x
EV / Sales 2028 * 10.1x
Free-Float
62.26%
Yield 2027 *
0.1%
Yield 2028 * 0.13%
1 day+0.12%
1 week-3.03%
Current month+20.39%
1 month+23.61%
3 months+38.00%
6 months+71.73%
Current year+51.12%
1 week 22,700
Extreme 22700
23,899
1 month 18,474.8
Extreme 18474.8
23,899
Current year 11,500
Extreme 11500
23,899
1 year 11,500
Extreme 11500
23,899
3 years 3,424.45
Extreme 3424.45
23,899
5 years 965.85
Extreme 965.85
23,899
10 years 247.3
Extreme 247.3
23,899
Manager TitleAgeSince
Chief Executive Officer 47 01/04/2026
Director of Finance/CFO - 23/11/2022
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 50 01/01/2002
Chairman 82 07/01/1984
Director/Board Member 47 01/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%-3.03%+65.53%+470.56% 3.07B
-1.06%+4.27%+73.34%+125.12% 1,111B
+0.53%+4.10%+52.35%+65.45% 658B
+0.48%+6.18%+26.21%+81.27% 467B
+0.92%+4.97%+42.94%+43.69% 369B
+1.25%+4.00%+25.87%+42.82% 301B
+3.02%+7.92%+4.24%+16.06% 256B
-0.36%+5.45%+50.57%+72.33% 240B
+2.86%+5.27%-15.42%-52.34% 207B
+1.38%+7.09%+29.62%+94.90% 182B
Average +1.10%+3.73%+35.53%+95.99% 379.41B
Weighted average by Cap. +1.12%+4.67%+44.14%+73.40%

Financials

2027 *2028 *
Net sales 24.43B 256M 219M 205M 188M 354M 357M 2.42B 943M 12.32B 962M 941M 40.78B 29.27B 307M 263M 246M 225M 424M 428M 2.9B 1.13B 14.75B 1.15B 1.13B 48.85B
Net income 4.8B 50.3M 43.08M 40.3M 36.86M 69.56M 70.2M 475M 185M 2.42B 189M 185M 8.01B 6.26B 65.67M 56.24M 52.62M 48.13M 90.82M 91.65M 621M 242M 3.16B 247M 241M 10.46B
Net Debt 2.56B 26.85M 22.99M 21.51M 19.68M 37.13M 37.47M 254M 98.87M 1.29B 101M 98.6M 4.27B 979M 10.27M 8.79M 8.23M 7.52M 14.2M 14.33M 97.01M 37.81M 494M 38.54M 37.7M 1.63B
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
25/08/26 ₹22,954.75 +0.12% 949
24/08/26 ₹22,926.10 -1.58% 796
21/08/26 ₹23,294.80 -1.14% 912
20/08/26 ₹23,562.25 +1.14% 2,128
19/08/26 ₹23,296.85 -0.10% 1,230
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
22,954.75INR
Average target price
24,334.75INR
Spread / Average Target
+6.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock